6-Bromo-2-naphthol
- CAS NO.:15231-91-1
- Empirical Formula: C10H7BrO
- Molecular Weight: 223.07
- MDL number: MFCD00004081
- EINECS: 239-279-0
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-13 23:13:44
What is 6-Bromo-2-naphthol?
Chemical properties
off-white to beige powder
The Uses of 6-Bromo-2-naphthol
6-Bromo-2-naphthol is a flavonoid molecule that shows steroid hormone activity and may be useful on anticancer therapy.
Definition
ChEBI: A member of the class of naphthols that is 2-naphthol carrying an additional bromo substituent at position 6.
Purification Methods
Crystallise the naphthol from EtOH or *C6H6/pet ether (m 128o). The benzoyl derivative has m 122o, (from EtOH). [Ruggli & Michels Helv Chim Acta 14 779 1931, Beilstein 6 H 651, 6 II 605, 6 III 2996.]
Properties of 6-Bromo-2-naphthol
| Melting point: | 122-124 °C (lit.) |
| Boiling point: | 130°C (rough estimate) |
| Density | 1.4412 (rough estimate) |
| refractive index | 1.5700 (estimate) |
| storage temp. | Inert atmosphere,Room Temperature |
| solubility | Chloroform, Methanol |
| form | Powder |
| pka | 9.26±0.40(Predicted) |
| color | Off-white to beige |
| BRN | 1100270 |
| CAS DataBase Reference | 15231-91-1(CAS DataBase Reference) |
| NIST Chemistry Reference | 2-Naphthalenol, 6-bromo-(15231-91-1) |
| EPA Substance Registry System | 6-Bromo-2-naphthol (15231-91-1) |
Safety information for 6-Bromo-2-naphthol
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P271:Use only outdoors or in a well-ventilated area. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for 6-Bromo-2-naphthol
6-Bromo-2-naphthol manufacturer
New Products
Cyclopentane-1,2-dione 2,6-Dibromoaniline 5-Hydroxy-3,9-dimethyl-7H-benzo[c]fluoren-7-one Methyl 4-(acetyloxy)-6-methoxy-1-(4-methoxyphenyl)-2naphthalenecarboxylate 4-Hydroxy-6,7-dimethoxy-1-phenyl-2naphthalenecarboxylic acid (3,5-Dibromophenyl)[4-(trifluoromethyl)phenyl]methanone (4-butoxyphenyl)(4-fluorophenyl)methanone (4-Bromophenyl)(3,4-dimethoxyphenyl)methanone Cefuroxime EP Impurity-A N-Nitroso hydroxy Cetrizine EP Impurity-A Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity Lantanoprost rc B Clidinium Bromide Impurity N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide 4-Ethyl-4-hydroxy-1,4,7,8-tetrahydro-3H,10H-spiro[pyrano[3,4-f]indolizine-6,2'-[1,3]dioxolane]-3,10-dione (E)-N'-(2-cyano-4-nitrophenyl)- N,N-dimethylformimidamide 2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid Benzyl-N,4-dimethylpiperidine-3- amine dihydrochloride 5-bromopyridin-2-amine 2-Chloro Benzylcyanide 3,4 Diethoxy Benzylcyanide 3-chlorobenzyl cyanide 3,4 Dimethoxy BenzylcyanideRelated products of tetrahydrofuran







You may like
-
15231-91-1 6-Bromo-2-naphthol, 97% 98%View Details
15231-91-1 -
15231-91-1 98%View Details
15231-91-1 -
6-Bromo-2-naphthol 98%View Details
15231-91-1 -
6-Bromo-2-naphthol, 97% CAS 15231-91-1View Details
15231-91-1 -
6-Bromo-2-naphthol CAS 15231-91-1View Details
15231-91-1 -
6-Bromo-2-Napthol pure CAS 15231-91-1View Details
15231-91-1 -
6-Bromo-2-naphthol CAS 15231-91-1View Details
15231-91-1 -
6 BROMO 2 NAPTHOLView Details
15231-91-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

